Used in research and development for targeted cancer therapies, particularly in the inhibition of specific kinase enzymes involved in tumor growth and progression. Shows potential in treating solid tumors and hematologic malignancies by blocking signaling pathways that drive cancer cell proliferation and survival. Currently under investigation in preclinical and clinical studies to evaluate its efficacy, safety, and pharmacokinetic profile in oncology applications.